Volume 36, Issue 11 pp. 2299-2307
Original Research

Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary

José M. Domínguez MD

Corresponding Author

José M. Domínguez MD

Departments of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Address correspondence to José M. Domínguez, MD, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Lira 85, Fifth Floor, 8330074 Santiago, Chile. E-mail: [email protected]Search for more papers by this author
Flavia Nilo MD

Flavia Nilo MD

Departments of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for more papers by this author
Tania Contreras

Tania Contreras

Departments of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for more papers by this author
Rocío Carmona

Rocío Carmona

Departments of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for more papers by this author
Nicolás Droppelmann MD

Nicolás Droppelmann MD

Departments of Surgery, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for more papers by this author
Hernán González MD, PhD

Hernán González MD, PhD

Departments of Surgery, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for more papers by this author
Virginia Iturrieta MD

Virginia Iturrieta MD

Departments of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for more papers by this author
R. Michael Tuttle MD

R. Michael Tuttle MD

Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for more papers by this author
First published: 24 May 2017
Citations: 8

We thank Lorena Mosso, MD, for her generosity in sharing her registry of patients.

Abstract

Objectives

Follow-up of patients with low-risk differentiated thyroid cancer treated with total thyroidectomy and radioiodine requires neck sonography and thyroglobulin (Tg). The need to stimulate Tg is controversial. The goal of this study was to compare the diagnostic performances of sonography plus suppressed or stimulated Tg in low-risk thyroid cancer.

Methods

After total thyroidectomy and radioiodine, patients with low-risk thyroid cancer were retrospectively identified as having structural or biochemical persistence/recurrence. We compared the diagnostic performance of suppressed and stimulated Tg to detect persistence/recurrence.

Results

We included 148 patients with low-risk thyroid cancer who were followed for a median of 3.7 years. Persistence/recurrence was found in 8 patients (5.4%; 5 structural disease and 3 biochemical disease). Thyroglobulin was not stimulated in 72 patients (group 1) and stimulated in 76 (group 2). In group 1, 5 patients (6.9%) had structural neck persistence/recurrence (3 with suppressed Tg ≥ 1 ng/mL and 2 with suppressed Tg < 1 ng/mL). Four patients underwent surgery, and 1 was surveilled. All 5 patients had suppressed Tg lower than 1 ng/mL at the end of follow-up. In group 2, stimulated Tg did not identify additional cases of structural persistence/recurrence but classified 3 patients (3.9%) as having biochemical persistence/recurrence. One patient received a second dose of radioiodine, and the other 2 were surveilled; all were without disease at the end of follow-up. Suppressed and stimulated Tg had negative predictive values for persistence/recurrence of 97% and 100%, respectively.

Conclusions

In low-risk thyroid cancer treated with total thyroidectomy and radioiodine, sonography and suppressed or stimulated Tg have similar negative predictive values for persistence/recurrence. Importantly, the coexistence of negative sonographic findings and suppressed Tg lower than 1 ng/mL makes the addition of stimulated Tg unlikely to identify clinically important disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.